Building a strong brand
As a leading life science investment company in the Nordics, we understand the importance of strong investor relations for growth companies in the life science industry. That is why we have dedicated ourselves to helping selected businesses build a strong brand in capital markets and communicate effectively with investors.
Expertise in life science and finance
Our team at Sciety has a unique blend of expertise in life science, finance, and investor relations. We have in-depth knowledge of the life science industry and are in constant dialogue with life science investors. This allows us to provide companies with tailored communication services that will help them to build strong investor relations.
Communicating effectively
We understand the challenges of producing relevant content and selecting the right channels. That is why we are here to help. Whether it is through press releases, shareholder updates, or digital marketing, we will work with you to create content that effectively communicates your business and progress.
Extensive experience in investor relations
Sciety supports selected life science and health tech companies to communicate their message clearly and effectively, helping them to reach a wider audience and build a stronger brand in capital markets. We have clients ranging from pharma to health tech, and we work with both listed and unlisted companies.
"We have been working with Sciety for several years now. What sets them apart is their ability to understand our business, communicate complex scientific concepts to non-scientific professionals, and help us communicate the business impact of our R&D efforts."
Christopher Aulin, CEO
Capitainer
We are dedicated to helping selected companies reach their full potential and make a lasting impact on tomorrow's life science and healthcare
Sign up for news
Sign up for our newsletter to receive our latest news, insights and invitations to seminars.
Get in touch
Do you want to learn more about how we can help you communicate more effectively with investors? Please drop us an email at .